Bethesda, MD (PRWEB) May 25, 2017
CME Outfitters is proud to share preliminary findings from a live symposium entitled, A Framework for Successful Intrathecal Pain Management: New Insights from the 2017 Polyanalgesic Consensus Conference (PACC) Guidelines, held at the American Academy of Pain Medicine (AAPM) Annual Meeting in Orlando this March. The symposium, which was also broadcast via livestream for clinicians who were unable to attend in person, featured renowned expert faculty presenters, Gladstone C. McDowell, II, MD, and Jason E. Pope, MD, DABPM, FIPP, and state-of-the-art iPad ARRAY audience response technology. An enduring video replay of the 75-minute symposium is now available for participation and CE credit through March 18, 2018.
This activity, which was supported by an educational grant from Jazz Pharmaceuticals, Inc., focused on the new 2017 PACC guidelines and translating the updates and recommendations to clinical decision-making for patients with refractory chronic pain who are candidates for intrathecal (IT) therapy. Attendees also learned best approaches to applying PACC recommendations for trialing of appropriate patients and implementing dosing and titration strategies in patients to maximize results while also mitigating risks.
Preliminary outcomes findings showed a large overall effect size (.88 from pre- to post-survey [large = .8]), with dramatic improvements in knowledge, behavior, and confidence among clinicians treating patients with refractory chronic pain who may be IT therapy candidates. Knowledge improvements included 112% more participants identifying the dose that should be used for initiating IT opioids and ziconotide (n= 72, p < .001), and 217% more participants recognizing the first choice treatment for cancer- or non-cancer related pain (n= 74, p < .001). Improvements in behavior included a 247% increase in participants translating updates from 2017 PACC guidelines to clinical decision making related to IT therapy (n= 78, p < .001), while 218% more participants utilized the recommendations for trialing candidates for IT therapy (n= 78, p < .001). [Note: Pre-survey actual vs. post-survey intent to change.] Improvements in confidence showed that 42% more participants were confident in implementing IDD dosing and titration strategies to maximize result and mitigate risk (n= 78, p = .039). Overall, 75% of attendees said the activity would change their practice, while 82% said that at least half of the educational content was new to them.
Participants of the live symposium, both in person and via livestream, have provided exceptional feedback regarding the program: “I had never heard of the PACC guidelines before today so learning about them and trying to utilize them will be helpful;” “This was well done. I have a history of IT therapy with opioids for pain, but treatment is going very poorly…IT seems like a good approach;” “Content was very important to all team members;” “The activity assisted me in understanding the details my interventionalist uses in the decision-making process.”
To participate in the archived replay of this activity, click here.
About CME Outfitters, LLC
CME Outfitters develops and distributes live, recorded and web-based, outcomes- and evidence-based educational activities to thousands of clinicians each year and offers expert accreditation and outcome services for non-accredited organizations. CME Outfitters focuses on delivering education to specialty audiences, with strong expertise in neuroscience, inflammatory, infectious, and autoimmune diseases, and cardiovascular disease. For a complete list of certified activities and more information, visit http://www.cmeoutfitters.com or call 877.CME.PROS (877.263.7767).
“CME Outfitters …
Improving Clinical Behavior … One Change at a Time”